Clothing naked quackery and legitimising pseudoscience, BMJ, vol.343, issue.sep20 3, p.5960, 2011. ,
DOI : 10.1136/bmj.d5960
College of Medicine or College of Quackery?, BMJ, vol.343, issue.jul12 3, p.4370, 2011. ,
DOI : 10.1136/bmj.d4370
Placebo controls, exorcisms, and the devil, The Lancet, vol.374, issue.9697, p.1234, 2009. ,
DOI : 10.1016/S0140-6736(09)61775-X
Evidence-Based Medicine, JAMA, vol.268, issue.17, pp.2420-2425, 1992. ,
DOI : 10.1001/jama.1992.03490170092032
The placebo response: science versus ethics and the vulnerability of the patient, World Psychiatry, vol.32, issue.2, pp.70-72, 2012. ,
DOI : 10.1016/j.wpsyc.2012.05.003
Active Albuterol or Placebo, Sham Acupuncture, or No Intervention in Asthma, New England Journal of Medicine, vol.365, issue.2, pp.119-12610, 2011. ,
DOI : 10.1056/NEJMoa1103319
Biological, clinical, and ethical advances of placebo effects, The Lancet, vol.375, issue.9715, pp.686-695, 2010. ,
DOI : 10.1016/S0140-6736(09)61706-2
Antidepressants versus placebo for depression in primary care, 2009. ,
DOI : 10.1002/14651858.CD007954
Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: What is the level of evidence?, Diabetes & Metabolism, vol.40, issue.3, pp.169-175, 2014. ,
DOI : 10.1016/j.diabet.2013.12.010
Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials, BMJ, vol.343, issue.jul26 1, p.4169, 2011. ,
DOI : 10.1136/bmj.d4169
URL : https://hal.archives-ouvertes.fr/hal-00698409
Effects of intensive glucose lowering in type 2 diabetes, N Engl J Med, vol.358, issue.24, pp.2545-2559, 2008. ,
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes, New England Journal of Medicine, vol.360, issue.2, pp.129-139, 2009. ,
DOI : 10.1056/NEJMoa0808431
Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings, JAMA, vol.311, issue.18, pp.1889-1900, 2014. ,
DOI : 10.1001/jama.2014.3628
???They won't do any harm and might do some good???: time to think again on the use of antidepressants?, British Journal of General Practice, vol.61, issue.582, pp.47-4910, 2011. ,
DOI : 10.3399/bjgp11X548983
Two Centuries of Assessing Drug Risks, New England Journal of Medicine, vol.367, issue.3, pp.193-197, 2012. ,
DOI : 10.1056/NEJMp1206652
The FDA and Drug Safety, Archives of Internal Medicine, vol.166, issue.18, pp.1938-1942, 1938. ,
DOI : 10.1001/archinte.166.18.1938
Adverse Events in Randomized Trials, Archives of Internal Medicine, vol.169, issue.19, 2009. ,
DOI : 10.1001/archinternmed.2009.313
Reporting of safety results in published reports of randomized controlled trials, Arch Intern Med, vol.169, pp.1756-1761, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00431492
The European Medicines Agency's plans for sharing data from clinical trials, BMJ, vol.346, issue.may08 1, p.2961, 2013. ,
DOI : 10.1136/bmj.f2961
Conflicts of interest at medical journals: the influence of industry-supported randomised trials on journal impact factors and revenue -cohort study, PLoS medicine, vol.7, issue.10, 2010. ,